Skip to main content
Clinical Trials/NL-OMON46734
NL-OMON46734
Completed
Phase 4

Evaluation of the patients* satisfaction and safety of a non-degradable urethral bulking agent for female stress urinary incontinence - Euro study

Academisch Medisch Centrum0 sites75 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
Academisch Medisch Centrum
Enrollment
75
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- \> 18 years
  • \- who underwent treatment with bulkinjection therapy Urolastic for stress urinary incontinence

Exclusion Criteria

  • Incapable of giving informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials